Fetal Cell Analysis From Maternal Blood

Sex: Female

Ages: 18 Years – N/A

Phase: NA

Enrollment: 1500

Sponsor: Menarini Biomarkers Singapore

Summary

The aim of this clinical study is the evaluation of clinical performance of a cell-based non-invasive test technology for fetal aneuploidies and segmental imbalances detection in a high-risk pregnancies population.

Eligibility Criteria

Inclusion Criteria:Participant has a viable singleton or twin pregnancyWomen who have already been selected by their treating physician to undergo an invasive fetal diagnostic procedureParticipant is at least 18 years old and can provide informed consentExclusion Criteria:Unable to provide informed consentPrenatal diagnosis of clinical ChorioamnionitisIntake of drugs or exposure to teratogenic agentsInfections that carry a risk of vertical transmissionKnown maternal viral diseases: HIV and HCV, HBV

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05671744). StuddyBuddy aggregates publicly available trial information.